Investors with the goal of beating the broader market often turn to stock selection. Strategic choices in individual stocks can have a profound impact on your wealth.
The price of Staar Surgical Co (NASDAQ: STAA) closed at $25.03 in the last session, up 3.17% from day before closing price of $24.26. In other words, the price has increased by $3.17 from its previous closing price. On the day, 1.31 million shares were traded. STAA stock price reached its highest trading level at $25.12 during the session, while it also had its lowest trading level at $24.115.
Ratios:
We take a closer look at STAA’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 4.05 and its Current Ratio is at 4.94. In the meantime, Its Debt-to-Equity ratio is 0.12 whereas as Long-Term Debt/Eq ratio is at 0.11.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of. The stock’s future direction. In the most recent recommendation for this company, Wells Fargo on April 21, 2025, initiated with a Equal Weight rating and assigned the stock a target price of $17.
Mizuho Downgraded its Outperform to Neutral on February 12, 2025, whereas the target price for the stock was revised from $45 to $17.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Aug 05 ’25 when WEISNER AIMEE S bought 1,750 shares for $26.87 per share.
WEISNER AIMEE S bought 13,491 shares of STAA for $362,523 on Aug 05 ’25. On Apr 08 ’25, another insider, BROADWOOD PARTNERS, L.P., who serves as the 10% Owner of the company, bought 178,127 shares for $15.32 each. As a result, the insider paid 2,729,095 and bolstered with 13,510,391 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, STAA now has a Market Capitalization of 1235333760 and an Enterprise Value of 1090949504. For the stock, the TTM Price-to-Sale (P/S) ratio is 5.50 while its Price-to-Book (P/B) ratio in mrq is 3.67. Its current Enterprise Value per Revenue stands at 4.861 whereas that against EBITDA is -14.947.
Stock Price History:
The Beta on a monthly basis for STAA is 0.95, which has changed by -0.18442488 over the last 52 weeks, in comparison to a change of 0.13837254 over the same period for the S&P500. Over the past 52 weeks, STAA has reached a high of $32.00, while it has fallen to a 52-week low of $13.50. The 50-Day Moving Average of the stock is -8.08%, while the 200-Day Moving Average is calculated to be 19.45%.
Shares Statistics:
According to the various share statistics, STAA traded on average about 1.65M shares per day over the past 3-months and 1465540 shares per day over the past 10 days. A total of 49.28M shares are outstanding, with a floating share count of 49.13M. Insiders hold about 0.46% of the company’s shares, while institutions hold 109.19% stake in the company. Shares short for STAA as of 1759190400 were 3050500 with a Short Ratio of 1.85, compared to 1756425600 on 3992554. Therefore, it implies a Short% of Shares Outstanding of 3050500 and a Short% of Float of 10.780000000000001.
Earnings Estimates
A comprehensive evaluation of Staar Surgical Co (STAA) is underway, with the input of 6.0 analysts contributing to its current rating.The consensus estimate for the next quarter is $0.07, with high estimates of $0.2 and low estimates of $0.0.
Analysts are recommending an EPS of between -$0.11 and -$1.26 for the fiscal current year, implying an average EPS of -$0.73. EPS for the following year is $0.22, with 6.0 analysts recommending between $0.63 and -$0.27.
Revenue Estimates
According to 9 analysts,. The current quarter’s revenue is expected to be $92.15M. It ranges from a high estimate of $111.9M to a low estimate of $83.04M. As of. The current estimate, Staar Surgical Co’s year-ago sales were $88.59MFor the next quarter, 9 analysts are estimating revenue of $78.51M. There is a high estimate of $84.1M for the next quarter, whereas the lowest estimate is $72.3M.
A total of 10 analysts have provided revenue estimates for STAA’s current fiscal year. The highest revenue estimate was $277.5M, while the lowest revenue estimate was $246.3M, resulting in an average revenue estimate of $257.35M. In the same quarter a year ago, actual revenue was $313.9MBased on 11 analysts’ estimates, the company’s revenue will be $319.75M in the next fiscal year. The high estimate is $379.4M and the low estimate is $271M.
